BNP Paribas Financial Markets
OPRX icon

BNP Paribas Financial Markets’s OptimizeRx OPRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Sell
200
-4,043
-95% -$23.2K ﹤0.01% 5587
2026
Q1 		$26.6K Sell
4,243
-14
-0.3% -$130 ﹤0.01% 4995
2025
Q4 		$52.2K Buy
4,257
+331
+8% +$5.41K ﹤0.01% 4669
2025
Q3 		$80.5K Sell
3,926
-148
-4% -$2.35K ﹤0.01% 4395
2025
Q2 		$55K Buy
4,074
+2,215
+119% +$24.2K ﹤0.01% 4226
2025
Q1 		$16.1K Sell
1,859
-20,449
-92% -$125K ﹤0.01% 4594
2024
Q4 		$108K Buy
22,308
+18,618
+505% +$104K ﹤0.01% 4136
2024
Q3 		$28.5K Buy
3,690
+2,414
+189% +$21.5K ﹤0.01% 3707
2024
Q2 		$12.8K Sell
1,276
-26,634
-95% -$293K ﹤0.01% 3701
2024
Q1 		$339K Buy
27,910
+20,634
+284% +$299K ﹤0.01% 3054
2023
Q4 		$104K Sell
7,276
-3,124
-30% -$30K ﹤0.01% 3386
2023
Q3 		$80.9K Buy
10,400
+6,078
+141% +$66.1K ﹤0.01% 3377
2023
Q2 		$61.8K Sell
4,322
-2,268
-34% -$32.3K ﹤0.01% 3407
2023
Q1 		$96.4K Buy
6,590
+4,014
+156% +$67.2K ﹤0.01% 3332
2022
Q4 		$43.3K Sell
2,576
-3,399
-57% -$58.8K ﹤0.01% 3449
2022
Q3 		$88.5K Buy
5,975
+264
+5% +$5.22K ﹤0.01% 3822
2022
Q2 		$156K Buy
5,711
+1,243
+28% +$36.8K ﹤0.01% 3189
2022
Q1 		$168K Sell
4,468
-3,605
-45% -$160K ﹤0.01% 3187
2021
Q4 		$501K Buy
8,073
+5,052
+167% +$383K ﹤0.01% 3008
2021
Q3 		$258K Buy
3,021
+2,458
+437% +$154K ﹤0.01% 2959
2021
Q2 		$34.9K Sell
563
-1,506
-73% -$76.6K ﹤0.01% 3391
2021
Q1 		$101K Sell
2,069
-622
-23% -$30K ﹤0.01% 3350
2020
Q4 		$83.9K Sell
2,691
-623
-19% -$15.3K ﹤0.01% 3297
2020
Q3 		$69.1K Buy
3,314
+2,814
+563% +$48.3K ﹤0.01% 3306
2020
Q2 		$6.51K Sell
500
-3,779
-88% -$41.1K ﹤0.01% 3892
2020
Q1 		$38.8K Buy
4,279
+2,290
+115% +$21.7K ﹤0.01% 3662
2019
Q4 		$20.4K Buy
1,989
+476
+31% +$5.39K ﹤0.01% 4000
2019
Q3 		$21.9K Buy
1,513
+1,482
+4,781% +$22.9K ﹤0.01% 3912
2019
Q2 		$502 Buy
+31
New +$419 ﹤0.01% 4403

Other funds holding OPRX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BAM
Bullseye Asset Management Denver, Colorado $197M AUM 20.63% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Financial Markets's OPRX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its OptimizeRx (OPRX) stake by 95% in Q2 2026, selling an estimated $23.2K and leaving 200 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #5587.

BNP Paribas Financial Markets first reported a position in OPRX in Q2 2019 and has held it in 29 quarters since. The position peaked at $501K in Q4 2021. 105 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • BNP Paribas Financial Markets held 200 shares of OptimizeRx worth $1.14K as of Q2 2026.
  • BNP Paribas Financial Markets sold 4,043 OptimizeRx shares in Q2 2026, an estimated $23.2K.
  • OptimizeRx made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5587 holding.
  • BNP Paribas Financial Markets first reported a position in OptimizeRx in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's OptimizeRx position peaked at $501K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.